All sites C00-96,D32-33,D42-43,D45-47,D76 5010 90.7 3.3 2.8 1.1 2.1
Mouth, pharynx C00-14 136 98.1 0.7 0.3 0.4 0.4
  Lip C00 11 100.0 - - - -
  Tongue C02 25 100.0 - - - -
  Mouth, other C03-06 37 99.5 - - - 0.5
  Salivary glands C07-08 10 91.7 2.1 2.1 2.1 2.1
  Pharynx C01,C09-14 54 97.0 1.5 0.4 0.7 0.4
Digestive organs C15-26 991 85.5 3.6 5.6 2.0 3.3
  Oesophagus C15 69 94.5 0.3 2.6 1.2 1.5
  Stomach C16 99 96.0 0.4 0.8 1.0 1.8
  Small intestine C17 23 95.7 1.7 0.9 - 1.7
  Colon C18 280 97.1 0.1 1.2 0.4 1.2
  Rectum, rectosigmoid C19-20 191 97.5 - 1.3 0.5 0.7
  Anus C21 6 100.0 - - - -
  Liver C22 104 74.3 4.6 11.8 3.9 5.4
  Gallbladder, bile ducts C23-24 30 68.9 9.9 7.3 5.3 8.6
  Pancreas C25 175 54.5 14.1 17.7 5.5 8.2
  Other digestive organs C26 15 57.3 12.0 10.7 4.0 16.0
Respiratory organs C30-39 572 69.3 14.7 9.2 2.8 4.0
  Nose, sinuses C30-31 8 100.0 - - - -
  Larynx, epiglottis C32 39 99.0 - 0.5 - 0.5
  Lung, trachea C33-34 518 66.7 16.0 10.1 3.0 4.2
  Mediastinum, pleura C38 3 56.3 18.8 12.5 6.3 6.3
Bone C40-41 9 93.6 4.3 2.1 - -
Melanoma of the skin C43 257 99.9 0.1 - - -
Skin, non-melanoma C44 271 99.9 0.1 - - -
Mesothelioma C45 29 96.6 0.7 - 0.7 2.1
Autonomic nervous system C47 1 100.0 - - - -
Soft tissues C48-49 29 98.6 - 0.7 0.7 -
Breast C50 8 100.0 - - - -
Male genital organs C60-63 1498 99.2 - 0.1 0.3 0.4
  Prostate C61 1419 99.2 - 0.1 0.3 0.4
  Testis C62 66 99.4 - 0.3 - 0.3
  Other male genital C60,C63 13 100.0 - - - -
Urinary organs C64-68 456 94.6 1.1 2.4 0.5 1.4
  Kidney C64 173 89.7 0.5 5.9 0.9 3.0
  Bladder and urinary tract2 C65-68 283 97.5 1.6 0.2 0.2 0.5
Eye C69 7 67.6 - 11.8 17.6 2.9
Brain, central nervous system C70-72,D32-33,D42-43 151 96.7 - 1.9 0.1 1.3
Thyroid gland C73 37 97.3 2.2 - 0.5 -
Other endocrine glands C74-75 6 80.6 - 12.9 3.2 3.2
Illdefined or unknown C76,C80 77 63.2 8.9 13.3 4.4 10.2
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 474 85.5 6.1 0.8 1.8 5.8
  Hodgkin lymphoma C81 28 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 206 98.8 0.4 - 0.3 0.5
  Malignant immunoproliferative diseases C88 6 83.9 - - 9.7 6.5
  Myeloma and other plasma cell tumors C90 67 78.0 6.5 3.3 5.1 7.1
  Leukaemia C91-95 107 73.0 16.7 0.4 1.9 8.1
  Myelodysplastic syndromes D46 18 32.6 13.5 - 5.6 48.3
  Myeloproliferaitive neoplasms D45,D47 42 76.7 8.6 2.4 2.4 10.0
Not included above
  Basal cell carcinoma of the skin 1368 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.